Australia's Sigma Healthcare falls after Jefferies trims PT on slower Chemist Warehouse sales growth

By Reuters News

** Shares of Australia's Sigma Healthcare SIG.AX fall as much as 5.1% to A$2.685, their biggest intraday pct drop since August 27

** Stock hits its lowest level since October 12

** Jefferies cuts its price target on the pharmacy retailer to A$3.15 from A$3.20 after the company's AGM update showed Australian Chemist Warehouse like-for-like sales growth slowed to 9.8% in FY27 year-to-date from 13.4% in FY26

** Brokerage says softer discretionary spending and fading impact of an initial GLP-1 sales boost weighed on Australian growth, though international operations accelerated

** Jefferies cuts its FY27 EPS forecast by about 2% and FY28 EPS forecast by about 3%

** Sigma stock down 6.6%, YTD, including session moves

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.